Autogenous aorto-iliac/femoral reconstruction is a successful option in the treatment of infection and other complex aortic problems. The SFPV grafts resist gram-positive and gram-negative infections. Reconstruction from these vein grafts allows eradication of infection and rapid healing of all wounds. In addition, this operation minimizes the risk of reinfection, and eliminates the problem of aortic stump blowout. These vein grafts have excellent long-term patency and aorto-iliac/femoral reconstructions from them are durable with correspondingly high limb salvage rates and minimal venous morbidity.
Ricotta JJ, Faggioli GL, Stella A., et al. Total excision and extra-anatomic bypass for aortic graft infection . Am J Surg162:145-149, 1991.
2.
Reilly LM, Stoney RJ, Goldstone J., Ehrenfeld WKImproved management of aortic graft infection: the influence of operation sequence and staging. J Vasc Surg5:421-431, 1987.
3.
Quinones-Baldrich WJ, Hernandez JJ, Moore WSLong-term results following surgical management of aortic graft infection. Arch Surg126:507-511, 1991.
4.
Schellack J. , Stewart MT, Smith RB, Perdue GD, Salam A.Infected aortobifemoral prosthesis—A dreaded complication. Am Surg54:137-141, 1988.
5.
Lorentzen JE , Nielsen OM, Arendrup H., et al. Vascular graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery98:81-86, 1985.
Yeager RA, Moneta GL, Taylor LM, Harris EJ Jr, McConnell DB, Porter JMImproving survival and limb salvage in patients with aortic graft infection . Am J Surg159:466—69, 1990 .
8.
Yeager RA, McConnell DB, Sasaki TM, Vetto RMAortic and peripheral prosthetic graft infection: differential management and causes of mortality. Am J Surg150:36-43, 1985.
9.
Bacourt F., Koskas F., and the FrenchUniversity Association for Research in Surgery. Axillobifemoral bypass and aortic exclusion for vascular septic lesions: A multicenter retrospective study of 98 cases. Ann Vasc Surg6:119-126, 1992.
10.
O'Hara PJ, Hertzer NR, Beven EG, Krajewski LPSurgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg3:725-731, 1986.
11.
Trout HH, Kozloff L., Giordano JMPriority of revascularization in patients with graft enteric fistulas, infected arteries, or infected arterial prostheses. Ann Surg6:669-682, 1984.
12.
Olah A., Vogt M., Laske A., Carrell T., Bauer E., Turina M.Axillo-femoral bypass and simultaneous removal of the aortofemoral vascular infection site: is the procedure safe?Eur J Vasc Surg6:252-254, 1992.
13.
Schmitt DD, Seabrook GR, Bandyk DF, Towne JBGraft excision and extra-anatomic revascularization: the treatment of choice for the septic aortic prosthesis. J Cardiovasc Surg31:327-332, 1990.
14.
Turnipseed WD, Berkoff HA, Detmer DE, Acher CW, Belzer FOArterial graft infections. Delayed vs immediate vascular reconstruction. Arch Surg118:410-414, 1983.
15.
Seeger JM, Wheeler JR, Gregory RT, Snyder SO, Gayle RGAutogenous graft replacement of infected prosthetic grafts in the femoral position. Surgery93:39-45, 1983.
16.
Clagett GP, Bowers BL, Lopez-Viego MA, et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg218:239-249, 1993.
17.
Nevelsteen A., Lacroix H., Suy R.Autogenous reconstruction with the lower extremity deep veins: an alternative in the treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg22:129-134, 1995.
Clagett GP, Valentine RJ, Hagino RJAutogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability. J Vasc Surg25: 255-270, 1997.
20.
Ehrenfeld WK , Wilbur BG, Olcott CN, Stoney RJAutogenous tissue reconstruction in the management of infected prosthetic grafts. Surgery85:82-92, 1979.
21.
Quinones-Baldrich WJ, Gelabert HAAutogenous tissue reconstruction in the management of aortoiliofemoral graft infection. Ann Vasc Surg4:223-228, 1990.
22.
Lorentzen JE , Nielsen OMAortobifemoral bypass with autogenous saphenous vein in treatment of paninfected aortic bifurcation graft. J Vasc Surg3:666-668, 1986.
23.
Hakaim AG, Hertzer NR, O'Hara PJ, Krajewski LP, Beven EGAutogenous vein grafts for femorofemoral revascularization in contaminated or infected fields. J Vase Surg19:912-915, 1994.
24.
Valentine RJ , Hansen ME, Myers SI, Chervu A., Clagett GPThe influence of sex and aortic size on late patency following aortofemoral revascularization in young adults. J Vasc Surg21:296-306, 1995.
Sharp WJ, Hoballah JJ, Mohan CR, et al. The management of the infected aortic prosthesis: a current decade of experience. J Vasc Surg19:844-850, 1994.
27.
Kuestner LM , Reilly LM, Jicha DL, Ehrenfeld WK, Goldstone J., Stoney RJSecondary aortoenteric fistula: Contemporary outcome with use of extra-anatomic bypass and infected graft excision. J Vasc Surg21:184-196, 1995.
28.
Schulman ML , Badhey MR, Yatco R.Superficial femoral-popliteal veins and reversed saphenous veins as primary femoropopliteal bypass grafts: A randomized comparative study. J Vasc Surg6:1-10, 1987.
29.
Schanzer H. , Chiang K., Mabrouk M., Peirce ECUse of lower extremity deep veins as arterial substitutes: functional status of the donor leg. J Vasc Surg14:624-627, 1991.
Robinson JA , Johansen K.Aortic sepsis: is there a role for in situ graft reconstruction?J Vasc Surg13:677-684, 1991.
33.
Walker WE, Cooley DA, Duncan JM, Hallman GL Jr, Ott DA, Reul GJThe management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft. Ann Surg205:727-732, 1987.
34.
O'Mara CS, Williams GM, Ernst CBSecondary aortoenteric fistula, a 20 year experience. Am J Surg142:203-209, 1981.
